An NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells.
Ius T, Ciani Y, Ruaro ME, Isola M, Sorrentino M, Bulfoni M, Candotti V, Correcig C, Bourkoula E, Manini I, Pegolo E, Mangoni D, Marzinotto S, Radovic S, Toffoletto B, Caponnetto F, Zanello A, Mariuzzi L, Di Loreto C, Beltrami AP, Piazza S, Skrap M, Cesselli D.
Ius T, et al. Among authors: bulfoni m.
Neuro Oncol. 2018 May 18;20(6):776-787. doi: 10.1093/neuonc/nox234.
Neuro Oncol. 2018.
PMID: 29228370
Free PMC article.